Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Raghuveer Ranganathan
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
Cancer Research
Cancer Research
Oncology
Related publications
394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Making CAR T Cells a Solid Option for Solid Tumors
Frontiers in Immunology
Allergy
Immunology
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
247. Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Targeting the Adenosine 2A Receptor Enhances Chimeric Antigen Receptor T Cell Efficacy
Journal of Clinical Investigation
Medicine
Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors
OncoImmunology
Oncology
Allergy
Immunology
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
Clinical Cancer Research
Cancer Research
Oncology
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
Frontiers in Immunology
Allergy
Immunology